The pharmaceutical industry continues to be in acquisition mode with pharma giant Pfizer (NYSE:PFE) announcing its intention to acquire King Pharmaceuticals (NYSE:KG) for $3.6 billion. Pfizer and King Pharma have entered into a definitive merger agreement whereby Pfizer will acquire King Pharma for $14.25 per share. Offer Price Represents 40% Premium The offer price represents [...]